Martin Steinbach

The consulting firm EY anticipates up to ten IPOs in Germany in 2025. Stada, the generic drug manufacturer owned by private equity firms Bain and Cinven, could be one of the first to debut. Other potential candidates include Thyssenkrupp Marine Systems and KNDS.